A double-blind, placebo-controlled, multicenter study of cerebrolysin for Alzheimer's disease

被引：0
|
作者：
Bae, CY [1 ]
Cho, JY [1 ]
Cho, KH [1 ]
Oho, BH [1 ]
Choi, KG [1 ]
Lee, HS [1 ]
Jung, SP [1 ]
Kim, DH [1 ]
Choi, KD [1 ]
Cho, HS [1 ]
Lee, HT [1 ]
机构：
[1] Korean Geriatr Res Grp, Seoul, South Korea
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 1999年 / 47卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
A3
引用
收藏
页码：S2 / S2
页数：1
相关论文
共 50 条
  • [1] A double-blind, placebo-controlled, multicenter study of cerebrolysin for Alzheimer's disease
    Bae, CY
    Cho, CY
    Cho, K
    Oh, BH
    Choi, KG
    Lee, HS
    Jung, SP
    Kim, DH
    Lee, S
    Choi, GD
    Cho, H
    Lee, H
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (12) : 1566 - 1571
  • [2] Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent
    M. Panisset
    S. Gauthier
    H. Moessler
    M. Windisch
    [J]. Journal of Neural Transmission, 2002, 109 : 1089 - 1104
  • [3] Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent
    Panisset, M
    Gauthier, S
    Moessler, H
    Windisch, M
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2002, 109 (7-8) : 1089 - 1104
  • [4] Cerebrolysin in Alzheimer's disease: A Randomized, Double-blind, Placebo-controlled Trial with a Neurotrophic Agent
    Ruther, E.
    Kasper, S.
    Moessler, H.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2002, 4 (01) : 57 - 58
  • [5] Double-blind placebo-controlled study of velnacrine in Alzheimer's disease
    Zemlan, FP
    Keys, M
    Richter, RW
    Strub, RL
    [J]. LIFE SCIENCES, 1996, 58 (21) : 1823 - 1832
  • [6] A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease
    Ruether, E
    Husmann, R
    Kinzler, E
    Diabl, E
    Klingler, D
    Spatt, J
    Ritter, R
    Schmidt, R
    Taneri, Z
    Winterer, W
    Koper, D
    Kasper, S
    Rainer, M
    Moessler, H
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2001, 16 (05) : 253 - 263
  • [7] Results of a randomized, double-blind, placebo-controlled trial with the neurotrophic compound cerebrolysin in Alzheimer's disease patients
    Alvarez, A
    Laredo, M
    Sampedro, C
    Cacabelos, R
    Couceiro, V
    Vargas, M
    Aleixandre, M
    Illescas, E
    Linares, C
    Granizo, E
    Moessler, H
    [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S209 - S209
  • [8] A double-blind, placebo-controlled study of tacrine in Chinese patients with Alzheimer's disease
    Wong, WJ
    Liu, HC
    Fuh, JL
    Wang, SJ
    Hsu, LC
    Wang, PN
    Sheng, WY
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1999, 10 (04) : 289 - 294
  • [9] Dose-response effects of cerebrolysin in Alzheimer's disease patients: A randomized, double-blind, placebo-controlled trial
    Alvarez, XA
    Cacabelos, R
    Vargas, M
    Aleixandre, M
    Linares, C
    Granizo, E
    Moessler, H
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S383 - S383
  • [10] Efficacy of FPF 1070 (cerebrolysin) in patients with Alzheimer's disease - A multicentre, randomised, double-blind, placebo-controlled trial
    Xiao, SF
    Yan, HQ
    Yao, PF
    [J]. CLINICAL DRUG INVESTIGATION, 2000, 19 (01) : 43 - 53
12345